Mekonos

Mekonos

Mekonos is a company that creates cell-engineering platforms

All edits

Edits on 2 Dec, 2020
Daniel Frumkin"added artice"
Daniel Frumkin edited on 2 Dec, 2020
Edits made to:
Description (+60 characters)
Article (+1045 characters)
Topic thumbnail

Mekonos

Mekonos is a company that creates cell-engineering platforms

Article

Mekonos is a company that has created a platform that allows cell and gene therapies to be more accessible. The company was founded by Anil Narsimha, Greg Sitters, and Steven Banerjee in 2017, in San Francisco, California, United States.

Mekonos is responsible for developing over nine hundred therapeutic candidates, and expect roughly forty of them to be approved by the end of 2022. They developed their therapeutics through their platform solution, Iris, which is a System-on-a-Chip that allows for automated deliveries and precision for multiplexing.

Iris is a pharmaceutical and biotechnological platform that allows for targeted delivery and dose control of gene therapeutics that includes nucleic acids, protein complexes, and small molecules, and cell treatments such as primary, immune, and stem cells.

Microfluidics, micro-electro-mechanical systems, and chemistry to expand their catalogue of payloads and cell types. Their various methods of expansion allows Mekonos to scale their silicon technology for drug discover and development.

Edits on 29 Sep, 2020
Golden AI
Golden AI edited on 29 Sep, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Novartis
Edits on 13 Aug, 2020
Lax Mariappan
Lax Mariappan edited on 13 Aug, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Founded date
May 2017
Location
Edits on 4 Aug, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 4 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
CEO
Anil Narasimha
Edits on 2 Aug, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 2 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
1,400,000
Golden AI
Golden AI edited on 2 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Mekonos Seed Funding Round June 2018
Edits on 1 Aug, 2020
Aime Anne Nisay
Aime Anne Nisay edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 8 Jul, 2019
Golden AI"Remove default description"
Golden AI edited on 8 Jul, 2019
Edits made to:
Description (-7 characters)
Topic thumbnail

Mekonos

Company

Edits on 3 Jun, 2019
Golden AI
Golden AI edited on 3 Jun, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Steven Banerjee
Golden AI
Golden AI edited on 3 Jun, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Anil Narasimha
Edits on 17 Apr, 2019
Golden AI
Golden AI edited on 17 Apr, 2019
Edits made to:
Description (+7 characters)
Topic thumbnail

Mekonos

Company

Edits on 30 Mar, 2019
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 30 Mar, 2019
Edits made to:
Infobox (+9 properties)
People (+8 rows) (+16 cells) (+174 characters)
Topic thumbnail

Mekonos

Mekonos is a company that creates cell-engineering platforms

People

Name
Role
Related Golden topics

Anil Narasimha

Founder

Antony van Hoorn

Investor

Darwin Ling

Investor

David Booth

Investor

Meng Ting Chung

Employee

Milad Alucozai

Investor

Seth Bindernagel

Investor

Steven Banerjee

Founder

Infobox
Is a
Company
Industry
Drug discovery
Henry Ogolla"Initial topic creation"
Henry Ogolla created this topic on 30 Mar, 2019
Edits made to:
Topic thumbnail

 Mekonos

Mekonos is a company that creates cell-engineering platforms

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.